| Year | Citation |
|---|---|
| 2017 | Mousa, A., Naderpoor, N., de, Courten., Scragg, R., & de, Courten. (171001). 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort. Journal of Steroid Biochemistry and Molecular Biology, 173 (258-264). |
| 2017 | Naderpoor, N., Mousa, A., de, Courten., Scragg, R., Ranasinha, S., & de, Courten. (171001). Serum 25-hydroxyvitamin D concentration is not associated with glomerular filtration rate in a predominantly obese otherwise healthy population. Journal of Steroid Biochemistry and Molecular Biology, 173 (253-257). |
| 2016 | Riddell, M. A., Dunbar, J. A., Absetz, P., Wolfe, R., Li, H., Brand, M., Aziz, Z., Oldenburg, B., Reddy, P., & Hagger, V. (160824). Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes. BMC Public Health, 16(1), |
| 2016 |
Zurzolo, G. A., Koplin, J. J., Ponsonby, A. L., McWilliam, V., Dharmage, S., Heine, R. G., Tang, M. LK., Prescott, S., Campbell, D. E., & Loh, R. (160801). Consensus of stakeholders on precautionary allergen labelling: A report from the Centre for Food and Allergy Research. Journal of Paediatrics and Child Health, 52(8), (797-801). doi: 10.1111/jpc.13202 |
| 2016 | De, Courten., De, Courten., Soldatos, G., Dougherty, S. L., Straznicky, N., Schlaich, M., Sourris, K. C., Chand, V., Scheijen, J. LJM., & Kingwell, B. A. (160601). Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: A double-blind, randomized, crossover trial. American Journal of Clinical Nutrition, 103(6), (1426-1433). |
| 2016 | Zurzolo, G. A., De, Courten., Koplin, J., Mathai, M. L., & Allen, K. J. (160601). Is advising food allergic patients to avoid food with precautionary allergen labelling out of date?. Current Opinion in Allergy and Clinical Immunology, 16(3), (272-277). |
| 2016 |
De, Courten., Jakubova, M., De, Courten., Kukurova, I. J., Vallova, S., Krumpolec, P., Valkovic, L., Kurdiova, T., Garzon, D., & Barbaresi, S. (160501). Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial. Obesity, 24(5), (1027-1034). doi: 10.1002/oby.21434 |
| 2016 | Hallam, K. T., Livesay, K., Morda, R., Sharples, J., Jones, A., & De, Courten. (160101). Do commencing nursing and paramedicine students differ in interprofessional learning and practice attitudes: Evaluating course, socio-demographic and individual personality effects. BMC Medical Education, 16(1), |
| 2016 | Apostolopoulos, V., de, Courten., Stojanovska, L., Blatch, G. L., Tangalakis, K., & de, Courten. (160101). The complex immunological and inflammatory network of adipose tissue in obesity. Molecular Nutrition and Food Research, 60(1), (43-57). |
| 2015 | De, Courten., Kurdiova, T., De, Courten., Belan, V., Everaert, I., Vician, M., Teede, H., Gasperikova, D., Aldini, G., & Derave, W. (151006). Muscle carnosine is associated with cardiometabolic risk factors in Humans. PLoS ONE, 10(10), |
Key details
Areas of expertise
- Chronic disease prevention
- Epidemiology
- Public health
- Clinical research
- Research ethics and governance
Available to supervise research students
Available for media queries
About Maximilian de Courten
Professor Maximilian de Courten is a medical and public health graduate with an expertise in chronic disease prevention (mental health issues included) with a focus on policy and evidenced-based large-scale solutions.
Professor de Courten provides consulting services to organisations devoted to the promotion of mental health and wellbeing in the workplace through the prevention of mental injury and illness. He is involved in the improvement and promotion of mental health through commercial health platforms.
Professor Maximilian de Courten is a Global Public Health expert who has studied and worked in several countries. He has more than 25 years’ experience in interventions including:
- the identification of determinants of chronic diseases
- management of clinical trials
- development of community-based programs and international government programs
- development of policies for chronic disease prevention and control.
Qualifications
- MPH, University of Arizona, Tuscan, Arizona, USA, 1996
- MD (thesis), University of Basel, Switzerland, 1991
- Swiss Medical Diploma, Bern, Switzerland, 1990
Key publications
Maximilian has over 276 publications, with a selection listed here.
A more comprehensive list of Maximilian's publications is available in the VU Research Repository.
Journal article (showing 10 of 224)
Research funding for the past 5 years
Please note:
- Funding is ordered by the year the project commenced and may continue over several years.
- Funding amounts for contact research are not disclosed to maintain commercial confidentiality.
- The order of investigators is not indicative of the role they played in the research project.
2018
|
Preventing a T1D Progression via a Tolerance Inducing Vaccine
From: Juvenile Diabetes Research Foundation Australia
Other investigators: Prof Vasso Apostolopoulos
For period: 2018-2020
|
Not disclosed |
Supervision of research students at VU
Available to supervise research students
Available for media queries
Currently supervised research students at VU
| No. of students | Study level | Role |
|---|---|---|
| 1 | PhD Integrated | Associate supervisor |
| 1 | PhD Integrated | Principal supervisor |
| 2 | PhD | Principal supervisor |
Currently supervised research students at VU
| Students & level | Role |
|---|---|
| PhD Integrated (1) | Associate supervisor |
| PhD Integrated (1) | Principal supervisor |
| PhD (2) | Principal supervisor |
Completed supervision of research students at VU
| No. of students | Study level | Role |
|---|---|---|
| 2 | PhD | Associate supervisor |
| 1 | PhD | Principal supervisor |
| 1 | Master of Research | Principal supervisor |
Completed supervision of research students at VU
| Students & level | Role |
|---|---|
| PhD (2) | Associate supervisor |
| PhD (1) | Principal supervisor |
| Master of Research (1) | Principal supervisor |
Other supervision of research students
At the University of Copenhagen:
• 3 PhD students (Public Health)
• 3 MIH students (Master of International Health)
At Monash University:
• 3 PhD student (Public Health)
• 1 Dr PH student (Public Health)
• 1 MPH student
Teaching activities & experience
Created a post-graduate unit in Chronic Disease Prevention and Control incl. an online delivery modus within the Monash MPH program which was Australia's first such unit.
Key academic roles
| Dates | Role | Department / Organisation |
|---|---|---|
| Feb 2014 - Jan 2018 |
Director
|
Centre for Chronic Disease, Victoria Univeristy |
| Jan 2010 - Feb 2014 |
Professor of Global Public Health
|
Copenhagen University, Denmark |
| Dec 2005 - Dec 2009 |
Associate Professor of Clinical Epidemiology
|
Monash University, Melbourne |
| Dates | Role & Department/Organisation |
|---|---|
| Feb 2014 -
Jan 2018
|
Director
Centre for Chronic Disease, Victoria Univeristy |
| Jan 2010 -
Feb 2014
|
Professor of Global Public Health
Copenhagen University, Denmark |
| Dec 2005 -
Dec 2009
|
Associate Professor of Clinical Epidemiology
Monash University, Melbourne |
Key industry, community & government roles
| Dates | Role | Department/Organisation |
|---|---|---|
| Sep 2019 - Dec 2022 |
Senior NCD advisor (consultant) and Technical Lead
|
The World Bank Group, Kingdom of Saudi Arabia |
| Jan 2002 - Jun 2004 |
Medical Officer, Noncommunicable Diseases
|
World Health Organization, South Pacific Office |
| Jul 2000 - Jan 2002 |
Co-ordinator of NCD Risk Factor Surveillance
|
World Health Organization, Geneva, Switzerland |
| Dates | Role & Department/Organisation |
|---|---|
| Sep 2019 - Dec 2022 |
Senior NCD advisor (consultant) and Technical Lead
The World Bank Group, Kingdom of Saudi Arabia |
| Jan 2002 - Jun 2004 |
Medical Officer, Noncommunicable Diseases
World Health Organization, South Pacific Office |
| Jul 2000 - Jan 2002 |
Co-ordinator of NCD Risk Factor Surveillance
World Health Organization, Geneva, Switzerland |
